N3A-21727-70931
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 900 / CA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swelling of lymph node in injection sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2021-01-01
- 2021-01-10
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-10
- 2021-02-17
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen auxiliary lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-20
- 2021-10-26
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat , fatigue, congestion, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-28
-
2022-09-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Swelling of lymph node in injection side
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen auxiliary lymph node
Release 12 — 12 months, dose 3
Symptoms: Sore throat , fatigue, congestion, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release